Association between Helicobacter pylori infection and angiographically demonstrated coronary artery disease: A

Xin-Juan Yu1, Xuan Yang2, Lei Feng3

  • 1Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong 266000, P.R. China.

Insights

Helicobacter pylori infection may increase the risk of coronary artery disease (CAD). This meta-analysis found a significant association, particularly in younger individuals and certain ethnicities.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Coronary artery disease (CAD) is a major global cause of mortality.
  • The precise etiology and pathogenesis of CAD remain incompletely understood.
  • Investigating potential infectious links to CAD is crucial for understanding disease development.

Purpose of the Study:

  • To conduct a meta-analysis estimating the association between Helicobacter pylori (H. pylori) infection and the risk of CAD.
  • To evaluate the strength of this association using pooled data from eligible studies.
  • To explore potential moderating factors such as age and geographical region.

Main Methods:

  • A comprehensive literature search was performed for studies published before August 14, 2014.
  • Meta-analytical methods (fixed or random effects) were employed to pool data from 26 cross-sectional studies.
  • Odds ratios (OR) with 95% confidence intervals (CI) were calculated to quantify the association.

Main Results:

  • Helicobacter pylori infection was significantly associated with an increased risk of CAD (OR: 1.96, 95% CI: 1.47-2.63).
  • After adjusting for confounding factors, the association remained significant (OR: 1.42, 95% CI: 1.09-1.86).
  • The association was stronger in younger individuals and observed in studies from Europe and the USA.

Conclusions:

  • A potential association exists between H. pylori infection and an elevated risk of CAD.
  • Age and ethnicity may influence the strength of the H. pylori-CAD association.
  • Further research is warranted to elucidate the causal mechanisms linking H. pylori to cardiovascular disease.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
722
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
959
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.4K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.7K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K